Dr Reddy's launches generic pregabalin capsules in US

Dr Reddy’s Laboratories on Tuesday said it has launched Pregabalin capsules, used to treat neuropathic pain, in the US market. The company has launched the product after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy’s Labs said in a statement.

The product is a generic version of C P Pharmaceuticals International C V's Lyrica capsules which had US sales of around USD 5,462 million for the twelve months ended May 2019. The Hyderabad-based firm said its Pregabalin capsules are available in strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg in bottle count sizes of 90.

Shares of the company were trading 2.77 per cent down at Rs 2,579.20 apiece on the BSE.